We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Relief Therapeutics Holdings AG (QB) | USOTC:RLFTF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.1236 | -2.86% | 4.191 | 4.00 | 4.45 | 4.191 | 4.191 | 4.191 | 153 | 21:01:02 |
June 17, 2021 -- InvestorsHub NewsWire -- via pennymillions/IQST
iQSTEL, Inc. (OTCQB: IQST) Announced a new Electric Vehicle Division today growing out of its initiative with Alternet Systems, Inc. (USOTC: ALYI). ALYI’s PPS doubled yesterday on high volume.
The IQST PPS is up breaking through a 20 Day MA of $0.53, well above the 200 Day MA of $0.46 and heading toward the 50 Day MA of $0.62.
The number of shares issued and out (I/O) did not increase between the 2020 year end report and the Q1 2021 report. The I/O is steady at 136,881,964 and notably, the company reported elimination of all convertible debt.
The number of shares increased notably from 85,373,720 reported Q3 2020 and the publication of the annual report. Between the two reports, the company issued a registration statement in conjunction with a fund raising to eliminate debt and invest in growth.
With the stock trading for some time now steadily in the $0.50 range, the increase in I/O appears to have been digested by the market.
IQST’s deeper entry into the hot EV market could be the trigger that heads the PPS back toward its $2.00 52-Week High reached earlier this year.
Other stocks on the move include PQEFF and RLFTF
SOURCE: pennymillions/IQST
1 Year Relief Therapeutics (QB) Chart |
1 Month Relief Therapeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions